Group 1 - The core viewpoint of the report emphasizes the importance of reviewing the full semi-annual report for a comprehensive understanding of the company's operational results, financial status, and future development plans [1] - The board of directors, supervisory board, and senior management guarantee the authenticity, accuracy, and completeness of the semi-annual report, taking legal responsibility for any false statements or omissions [1] - The report indicates that there are no profit distribution plans or capital reserve conversion plans approved by the board during the reporting period [2] Group 2 - The company has reported significant changes in the operating conditions during the reporting period, with a focus on matters that have had or are expected to have a major impact on the company's operations [2] - The controlling shareholder and its concerted actors have a high proportion of pledged and judicially frozen shares, with 77.15% of their shares being judicially frozen and 60.22% pledged as of June 30, 2025 [3] - The risk of judicial disposal of shares held by the controlling shareholder and its concerted actors is high due to multiple lawsuits and significant amounts involved, which could potentially lead to a change in actual control of the company [3]
北海国发川山生物股份有限公司